Baptista, Igor L <br/><br/>
FoxO3a suppression and VPS34 activity are essential to anti-atrophic effects of leucine in skeletal muscle.  [electronic resource] 

 -  Cell and tissue research  08 2017 
 - 381-394 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0878 
<br/><br/><label>Standard No.: </label>10.1007/s00441-017-2614-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Nucleus--drug effects<br/>Class III Phosphatidylinositol 3-Kinases--metabolism<br/>Dexamethasone--pharmacology<br/>Forkhead Box Protein O3--metabolism<br/>Leucine--pharmacology<br/>Male<br/>Muscle Fibers, Skeletal--drug effects<br/>Muscle, Skeletal--drug effects<br/>Muscular Atrophy--pathology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats, Wistar<br/>Ubiquitination